Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Oliver Bachmann
Incretin Mimetics and Dipeptidyl Peptidase-4 Inhibitors in the Treatment of Type 2 Diabetes
European Endocrinology
Endocrine
Endocrinology
Metabolism
Autonomic Systems
Diabetes
Related publications
Role of Incretin, Incretin Analogues and Dipeptidyl Peptidase 4 Inhibitors in the Pathogenesis and Treatment of Diabetes Mellitus
Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors for the Treatment of Type 2 Diabetes Mellitus
Journal of thee Medical Sciences (Berkala Ilmu Kedokteran)
Renoprotective Effect of Dipeptidyl Peptidase-4 Inhibitors in Patients With Type 2 Diabetes Mellitus
Frontiers in Pharmacology
Pharmacology
Comparing Treatment Intensification and Clinical Outcomes of Metformin and Dipeptidyl Peptidase‐4 Inhibitors in Treatment Naïve Patients With Type 2 Diabetes in Japan
Journal of Diabetes Investigation
Internal Medicine
Endocrinology
Metabolism
Medicine
Diabetes
The Old and the New in the Treatment of Type 2 Diabetes: Focus on the Combination Therapy With Dipeptidyl Peptidase-4 Inhibitors and Metformin
Clinical Medicine Insights: Therapeutics
Medicine
Pharmacology
Pharmaceutical Science
The Nonglycemic Actions of Dipeptidyl Peptidase-4 Inhibitors
BioMed Research International
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Acquired Hemophilia a Associated With Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes Mellitus: A Single-Center Case Series in Japan
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
Erratum: Incretin Mimetics Vie for Slice of Type 2 Diabetes Market
Nature Biotechnology
Applied Microbiology
Biotechnology
Biomedical Engineering
Molecular Medicine
Bioengineering
Adherence to Oral Antihyperglycemic Agents (Dipeptidyl Peptidase-4 Inhibitors and Biguanides) and Its Associated Factors in Patients With Type 2 Diabetes
Yakugaku Zasshi
Pharmacology
Pharmaceutical Science
